PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
PBE vs. QQQ
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Key characteristics


PBEQQQ
YTD Return5.55%21.73%
1Y Return29.67%42.44%
3Y Return (Ann)-2.54%9.48%
5Y Return (Ann)5.94%20.93%
10Y Return (Ann)3.60%18.21%
Sharpe Ratio1.622.51
Sortino Ratio2.373.25
Omega Ratio1.281.45
Calmar Ratio0.873.18
Martin Ratio7.7211.66
Ulcer Index4.05%3.70%
Daily Std Dev19.28%17.16%
Max Drawdown-45.69%-82.98%
Current Drawdown-17.06%-1.17%

Correlation

-0.50.00.51.00.7

The correlation between PBE and QQQ is 0.68, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.

Performance

PBE vs. QQQ - Performance Comparison

In the year-to-date period, PBE achieves a 5.55% return, which is significantly lower than QQQ's 21.73% return. Over the past 10 years, PBE has underperformed QQQ with an annualized return of 3.60%, while QQQ has yielded a comparatively higher 18.21% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


0.00%5.00%10.00%15.00%20.00%JuneJulyAugustSeptemberOctober
9.29%
16.62%
PBE
QQQ

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


PBE vs. QQQ - Expense Ratio Comparison

PBE has a 0.59% expense ratio, which is higher than QQQ's 0.20% expense ratio.


PBE
Invesco Dynamic Biotechnology & Genome ETF
Expense ratio chart for PBE: current value at 0.59% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.59%
Expense ratio chart for QQQ: current value at 0.20% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.20%

Risk-Adjusted Performance

PBE vs. QQQ - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Invesco Dynamic Biotechnology & Genome ETF (PBE) and Invesco QQQ (QQQ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


PBE
Sharpe ratio
The chart of Sharpe ratio for PBE, currently valued at 1.62, compared to the broader market-2.000.002.004.006.001.62
Sortino ratio
The chart of Sortino ratio for PBE, currently valued at 2.37, compared to the broader market0.005.0010.002.37
Omega ratio
The chart of Omega ratio for PBE, currently valued at 1.28, compared to the broader market1.001.502.002.503.003.501.28
Calmar ratio
The chart of Calmar ratio for PBE, currently valued at 0.87, compared to the broader market0.005.0010.0015.000.87
Martin ratio
The chart of Martin ratio for PBE, currently valued at 7.72, compared to the broader market0.0020.0040.0060.0080.00100.00120.007.72
QQQ
Sharpe ratio
The chart of Sharpe ratio for QQQ, currently valued at 2.51, compared to the broader market-2.000.002.004.006.002.51
Sortino ratio
The chart of Sortino ratio for QQQ, currently valued at 3.25, compared to the broader market0.005.0010.003.25
Omega ratio
The chart of Omega ratio for QQQ, currently valued at 1.45, compared to the broader market1.001.502.002.503.003.501.45
Calmar ratio
The chart of Calmar ratio for QQQ, currently valued at 3.18, compared to the broader market0.005.0010.0015.003.18
Martin ratio
The chart of Martin ratio for QQQ, currently valued at 11.66, compared to the broader market0.0020.0040.0060.0080.00100.00120.0011.66

PBE vs. QQQ - Sharpe Ratio Comparison

The current PBE Sharpe Ratio is 1.62, which is lower than the QQQ Sharpe Ratio of 2.51. The chart below compares the historical Sharpe Ratios of PBE and QQQ, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.000.501.001.502.002.50JuneJulyAugustSeptemberOctober
1.62
2.51
PBE
QQQ

Dividends

PBE vs. QQQ - Dividend Comparison

PBE's dividend yield for the trailing twelve months is around 0.05%, less than QQQ's 0.61% yield.


TTM20232022202120202019201820172016201520142013
PBE
Invesco Dynamic Biotechnology & Genome ETF
0.05%0.02%0.00%0.00%0.04%0.00%0.00%0.57%0.38%1.12%0.55%0.00%
QQQ
Invesco QQQ
0.61%0.62%0.80%0.43%0.55%0.74%0.91%0.84%1.06%0.99%1.41%1.01%

Drawdowns

PBE vs. QQQ - Drawdown Comparison

The maximum PBE drawdown since its inception was -45.69%, smaller than the maximum QQQ drawdown of -82.98%. Use the drawdown chart below to compare losses from any high point for PBE and QQQ. For additional features, visit the drawdowns tool.


-25.00%-20.00%-15.00%-10.00%-5.00%0.00%JuneJulyAugustSeptemberOctober
-17.06%
-1.17%
PBE
QQQ

Volatility

PBE vs. QQQ - Volatility Comparison

Invesco Dynamic Biotechnology & Genome ETF (PBE) has a higher volatility of 4.66% compared to Invesco QQQ (QQQ) at 3.68%. This indicates that PBE's price experiences larger fluctuations and is considered to be riskier than QQQ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


3.00%4.00%5.00%6.00%7.00%8.00%9.00%JuneJulyAugustSeptemberOctober
4.66%
3.68%
PBE
QQQ